So, in addition to the receptor-targeted accumulation of PSMA-ligands in PCa lesions, the advantage of 68Ga-labelled radiopharmaceuticals for CLI is the high Cerenkov yield [16]. Here, FOLH1 is linked to posterior cortical atrophy.